<qa>  What is the name of the phase II trial?Drugs used in chemotherapy, such as CCI-779, work in different ways to stop cancer cells from dividing so they stop growing or die. This phase II trial is studying how well CCI-779 works in treating patients with recurrent or refractory B-cell non-Hodgkins lymphoma or chronic lymphocytic leukemia. 